This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hosseini-Mazinani, S. M.
Right arrow Articles by Sugimoto, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hosseini-Mazinani, S. M.
Right arrow Articles by Sugimoto, K.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 09 1996, 2152-2159, Vol 40, No. 9
Copyright © 1996 by the American Society for Microbiology. All rights reserved.

Recovery of active beta-lactamases from Proteus vulgaris and RTEM-1 hybrid by random mutagenesis by using a dnaQ strain of Escherichia coli

SM Hosseini-Mazinani, E Nakajima, Y Ihara, KZ Kameyama and K Sugimoto
Department of Chemistry II, Faculty of Science, Hokkaido University, Sapporo, Japan.

Proteus vulgaris and RTEM-1 beta-lactamases that belong to molecular class A with 37% amino acid similarity were examined to find the relationship between amino acid residues and activity of enzymes. MICs of ampicillin were > 2,000 micrograms/ml for Escherichia coli cells producing these enzymes. We have made 18 hybrid genes by substituting the coding region of the P. vulgaris beta-lactamase gene with the equivalent portions from the RTEM-1 gene. Most of these hybrids produced inactive proteins, but a few hybrid enzymes had partial or trace activity. From one of the hybrid genes (MIC of ampicillin, 100 micrograms/ml), we recovered three kinds of active mutants which provided ampicillin MICs of 1,000 micrograms/ml by the selection of spontaneous mutations in a dnaQ strain of E. coli. In these mutants, Leu-148, Met-182, and Tyr-274 were replaced with Val, Thr, and His, respectively. These amino acids have not been identified as residues with functional roles in substrate hydrolysis. Furthermore, from these hybrid mutants, we obtained a second set of mutants which conferred ampicillin MICs of 1,500 micrograms/ml. Interestingly, the second mutations were limited to these three amino acid substitutions. These amino acid residues which do not directly interact with substrates have an effect on enzyme activity. These mutant enzymes exhibited lower K(m) values for cephaloridine than both parental enzymes.


This article has been cited by other articles:

  • Sideraki, V., Huang, W., Palzkill, T., Gilbert, H. F. (2000). A secondary drug resistance mutation of TEM-1 beta -lactamase that suppresses misfolding and aggregation. Proc. Natl. Acad. Sci. USA 10.1073/pnas.011454198v1 [Abstract] [Full Text]  
  • Huang, W., Palzkill, T. (1997). A natural polymorphism in beta -lactamase is a global suppressor. Proc. Natl. Acad. Sci. USA 94: 8801-8806 [Abstract] [Full Text]  
  • Sideraki, V., Huang, W., Palzkill, T., Gilbert, H. F. (2001). A secondary drug resistance mutation of TEM-1 beta -lactamase that suppresses misfolding and aggregation. Proc. Natl. Acad. Sci. USA 98: 283-288 [Abstract] [Full Text]